DE69312579T2 - Arzneimittel zur Behandlung von Vulva-Dystrophie oder Vaginaltrockenheit - Google Patents

Arzneimittel zur Behandlung von Vulva-Dystrophie oder Vaginaltrockenheit

Info

Publication number
DE69312579T2
DE69312579T2 DE69312579T DE69312579T DE69312579T2 DE 69312579 T2 DE69312579 T2 DE 69312579T2 DE 69312579 T DE69312579 T DE 69312579T DE 69312579 T DE69312579 T DE 69312579T DE 69312579 T2 DE69312579 T2 DE 69312579T2
Authority
DE
Germany
Prior art keywords
medicines
vaginal dryness
vulvar dystrophy
treat vulvar
treat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69312579T
Other languages
English (en)
Other versions
DE69312579D1 (de
Inventor
David Frederick Horrobin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scotia Holdings PLC
Original Assignee
Scotia Holdings PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings PLC filed Critical Scotia Holdings PLC
Publication of DE69312579D1 publication Critical patent/DE69312579D1/de
Application granted granted Critical
Publication of DE69312579T2 publication Critical patent/DE69312579T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
DE69312579T 1992-05-27 1993-05-19 Arzneimittel zur Behandlung von Vulva-Dystrophie oder Vaginaltrockenheit Expired - Fee Related DE69312579T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929211229A GB9211229D0 (en) 1992-05-27 1992-05-27 Fatty acid treatment

Publications (2)

Publication Number Publication Date
DE69312579D1 DE69312579D1 (de) 1997-09-04
DE69312579T2 true DE69312579T2 (de) 1998-03-05

Family

ID=10716100

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69312579T Expired - Fee Related DE69312579T2 (de) 1992-05-27 1993-05-19 Arzneimittel zur Behandlung von Vulva-Dystrophie oder Vaginaltrockenheit

Country Status (15)

Country Link
US (1) US5380757A (de)
EP (1) EP0572159B1 (de)
JP (1) JPH0640903A (de)
AT (1) ATE156015T1 (de)
AU (1) AU660223B2 (de)
CA (1) CA2096556A1 (de)
DE (1) DE69312579T2 (de)
DK (1) DK0572159T3 (de)
ES (1) ES2107622T3 (de)
GB (1) GB9211229D0 (de)
GR (1) GR3025178T3 (de)
NO (1) NO931923L (de)
NZ (1) NZ247660A (de)
TW (1) TW336171B (de)
ZA (1) ZA933469B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0707850A1 (de) * 1994-09-21 1996-04-24 Scotia Holdings Plc Verwendung von mehrfach ungesättigten Fettsäuren zur Herstellung eines Arzneimittels zur Behandlung von Brustschmerzen
US6251436B1 (en) 1995-09-29 2001-06-26 L.A.M. Pharmaceutical Corporation Drug preparations for treating sexual dysfunction
US6036977A (en) * 1995-09-29 2000-03-14 L.A.M. Pharmaceutical Corp. Drug preparations for treating sexual dysfunction
US5897880A (en) 1995-09-29 1999-04-27 Lam Pharmaceuticals, Llc. Topical drug preparations
US6387407B1 (en) 1995-09-29 2002-05-14 L.A.M. Pharmaceutical Corporation Topical drug preparations
US20050065161A1 (en) * 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
US6479545B1 (en) * 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
CA2408399A1 (en) * 2000-05-09 2001-11-15 Nitromed, Inc. Infrared thermography and methods of use
AU2001273636A1 (en) 2000-06-27 2002-01-08 Qualilife Pharmaceuticals Inc. Compositions and methods for treating females sexual response
US20020172712A1 (en) * 2001-03-19 2002-11-21 Alan Drizen Antiemetic, anti-motion sustained release drug delivery system
US20030138494A1 (en) * 2001-05-15 2003-07-24 L.A.M. Pharmaceutical Corporation Drug preparations for treating sexual dysfunction
WO2003105825A1 (en) * 2002-06-14 2003-12-24 Alcon, Inc. Use of hydroxyeicosatetraenoic acid compounds to treat vaginal dryness
CA2436650A1 (en) * 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
WO2006089348A1 (en) * 2005-01-20 2006-08-31 Kayban Pty Ltd Anti-microbial agent
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
CA2704371A1 (en) * 2007-11-01 2009-05-07 Wake Forest University School Of Medicine Compositions and methods for prevention and treatment of mammalian diseases
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
KR101419622B1 (ko) * 2009-12-30 2014-07-15 더 프록터 앤드 갬블 캄파니 오메가-6 지방산을 포함하는 로션 조성물을 포함하는 흡수 용품
US20110159074A1 (en) * 2009-12-30 2011-06-30 Raphael Warren Wipe Article Comprising Lotion Composition Comprising Omega-6 Fatty Acid And Method Of Improving Skin Barrier Function
US20120083747A1 (en) * 2010-10-01 2012-04-05 Leo Galland Vaginal renewal complex and applicator
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
US9682055B2 (en) 2014-06-04 2017-06-20 Dignity Sciences Limted Pharmaceutical compositions comprising DGLA and use of same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU556817B2 (en) * 1982-02-03 1986-11-20 Efamol Limited Topical application of a lithium salt and dihomo-alpha- linolenic acid
US5145686A (en) * 1982-02-03 1992-09-08 Efamol Limited Topical pharmaceutical compositions
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
US5059622A (en) * 1989-08-29 1991-10-22 Biosyn, Inc. Method for reducing blood pressure levels in hypertensive persons
GB9116054D0 (en) * 1991-07-24 1991-09-11 Efamol Holdings Preparation of fatty acid medicaments

Also Published As

Publication number Publication date
DE69312579D1 (de) 1997-09-04
CA2096556A1 (en) 1993-11-28
GB9211229D0 (en) 1992-07-08
GR3025178T3 (en) 1998-02-27
JPH0640903A (ja) 1994-02-15
AU660223B2 (en) 1995-06-15
EP0572159B1 (de) 1997-07-30
NO931923D0 (no) 1993-05-26
DK0572159T3 (da) 1998-03-09
TW336171B (en) 1998-07-11
US5380757A (en) 1995-01-10
AU3861193A (en) 1993-12-02
ZA933469B (en) 1994-09-26
ES2107622T3 (es) 1997-12-01
ATE156015T1 (de) 1997-08-15
NO931923L (no) 1993-11-29
EP0572159A1 (de) 1993-12-01
NZ247660A (en) 1997-06-24

Similar Documents

Publication Publication Date Title
DE69312579T2 (de) Arzneimittel zur Behandlung von Vulva-Dystrophie oder Vaginaltrockenheit
HK37694A (en) Fatty acids compositions
SE8902701D0 (sv) Fettsyrakomposition
DE3881299D1 (de) Retinoide zur behandlung lichtgeschaedigter haut.
NO940035D0 (no) Kolesterolester, samt anvendelse av slike estere
DE3875286D1 (de) Essentielle fettsaeure enthaltende zusammensetzungen.
AU6681790A (en) Method and composition for treating inflammatory bowel disorders
ATE70183T1 (de) Topische zubereitungen mit gehalt an teer und fettsaeuren.
AU554413B2 (en) Linoleic acid and essential fatty acid compositions as
DE69005062D1 (de) Fettsäuren zur Behandlung und Prävention von Hautschäden durch Radiotherapie.
ATE164518T1 (de) Verwendung von fettsäuren zur behandlung von abnormalen verkalkung des gewebes
ATE19855T1 (de) Pharmazeutische und diaetetische zusammensetzung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee